Mean Capability, Opportunity, and Motivation scores by DAT and country among people with TB. by Kevin Guzman (16474985)

Boxplots of average NH₃ ppm in cages with four female or four male mice (see key for male and female) across five cage changing cycles at KI, LUMC and UGA. by B. Ulfhake (6293984)

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

“…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

“…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

“…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

“…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”

Increases and decreases in resources. by Guangliang Li (194029)

Transient increase of DN1 and decrease of DN2, DN3 showed in <i>the Foxn1</i>^<i>lacZ</i> thymus. by Shiyun Xiao (75798)

Use of a multiplex HTG assay to identify confirmed hit siRNA pools that decrease expression of key gluconeogenic genes in addition to G6PC. by Ruojing Yang (323580)

Real-time PCR confirmation of randomly selected genes whose expression levels were either increased (red) or decreased (green) by a specific endoxifen concentration. by John R. Hawse (227611)

“…Solid lines represent the 1.5 fold cut-off used in the microarray analysis. …”

Overview of OmpA structure and points of allelic variation as previously described [46]. by Chunyu Liao (4436998)

CpG/c stimulated CLL B cells decrease LEF-1 expression and increase PRDM1 expression. by Albert Gutierrez Jr. (342562)

Cephalometric measurement points. by Lijuan Liu (136685)

Random forest model variable importance ranking by mean decrease in Gini value in the derivation dataset (<i>N</i> = 2,771). by Andrew F. Auld (8967719)

HFD modulates survival rate by decreasing parasite load in the hearts of infected mice during acute infection (n = 15). by Fnu Nagajyothi (37087)

“…(<b>b</b>) qPCR analysis demonstrates a significant decrease (5 fold) of parasites in the hearts of HFD fed infected mice compared to the infected RD fed mice. …”

Decrease in MRE11 expression and function leads to increased sensitivity towards PARP inhibition in endometrial carcinoma cell lines. by Romana Koppensteiner (578125)

Predicted distribution of boat sizes, given a 10 percentage point increase in the probability of interception. by Katherine Hoffmann Pham (11619125)

L1 animals lacking <i>adr-2</i> have decreased expression of genes regulated by insulin signaling. by Ananya Mahapatra (17041557)

Chemical inhibition of formins decreases actin pedestal assembly by EPEC, but not by KC12+EspF_U. by Katrina B. Velle (4330957)

Effect of ex vivo treatment with rhTGFβ1 or a TGFβ1 inhibitor on monocyte responses to rgE stimulation.... by Michael J. Johnson (5818168)

“…<p>Effect of ex vivo treatment with rhTGFβ1 or a TGFβ1 inhibitor on monocyte responses to rgE stimulation. …”